Cancer research
A new study published in European Urology Oncology has shed light on the treatment landscape of metastatic hormone-sensitive prostate cancer (mHSPC). The researchers aimed to describe treatment trajectories and clinical outcomes in a large, multicenter real-world data (RWD) cohort under the PIONEER project. The study analyzed data from eight European
Cancer research
Research conducted by Qingdao Municipal Hospital in Shandong, People's Republic of China, has shown that combining radiotherapy with anti-angiogenic therapy, immune checkpoint inhibitors, and chemotherapy can be effective in prolonging the survival of patients with advanced non-small cell lung cancer (NSCLC). The study, published in Frontiers in Oncology,
Cancer research
Researchers at the Yale University School of Medicine have made a significant breakthrough in understanding the role of asparagine-linked glycosylation protein 1 (ALG1) in lung cancer progression. According to a newly published study, ALG1 promotes aggressive phenotypes of lung adenocarcinoma cells by modulating N-linked glycosylation and endoplasmic reticulum (ER)-stress
Cancer research
A new study by researchers at the Iran University of Medical Sciences has highlighted the urgent need for financial protection strategies for patients with cancer or special diseases in health systems. The research, published in Health Research Policy and Systems, aimed to identify existing strategies for financial protection for patients
Cancer research
Researchers from the First Affiliated Hospital of Anhui Medical University have developed a novel NLR-based prognostic model that effectively stratifies hepatocellular carcinoma (HCC) patients by survival risk. This study aimed to evaluate the prognostic value and biological function of NLR genes in HCC. The researchers analyzed transcriptomic and clinical data
Cancer research
Researchers at Nanjing University of Chinese Medicine have made a significant breakthrough in the treatment of liver cancer using a novel delivery system. The Astragaloside II (ASII)-loaded neutrophil nanocarrier system, known as PG@AS-Neu, has been shown to exhibit potent anticancer effects while maintaining the integrity of the cancer-fighting
Cancer research
A new study published in the Journal of Heart Rhythm has revealed that early-onset atrial fibrillation (AF) in patients without underlying cardiovascular conditions is associated with a significantly increased risk of long-term cardiovascular complications, including heart failure, stroke, and mortality. The research, conducted by a team of scientists at Copenhagen
Cancer research
A new study has shed light on the genetic alterations and microRNAs (miRNAs) that play a crucial role in lung cancer progression. According to the research, lung cancer is the most frequently diagnosed type of cancer worldwide, with key genetic alterations involving driver gene mutations that significantly enhance cancer aggressiveness.
Cancer research
Research conducted at the University of California has estimated that implementation of a $2000 cap for outpatient prescriptions as authorized by the 2022 Inflation Reduction Act (IRA) would generate a meaningful reduction in out-of-pocket costs for high-cost Medicare Part D beneficiaries who received a diagnosis of cancer. The study, published
Cancer research
A new study from the Second Affiliated Hospital of Soochow University in Suzhou, People's Republic of China, has evaluated the efficacy of PRaG therapy, a combination of programmed cell death protein 1 (PD-1)/programmed cell death ligand 1 (PD-L1) inhibitors, radiotherapy, and granulocyte-macrophage colony-stimulating factor, in overcoming resistance
Cancer research
Researchers from National Cancer Center Hospital East in Japan have conducted a comprehensive study to evaluate the chronological changes in clinical outcomes associated with oxaliplatin-based doublet chemotherapy and molecular targeted agents in metastatic colorectal cancer patients. The study utilized data from the Aide et Recherche en Cancerologie Digestive (ARCAD) database,
Cancer research
Researchers at Hebei General Hospital in Hebei, People's Republic of China, have made significant discoveries about the role of ammonia-induced cell death (AID) in gastric adenocarcinoma (STAD). Their study, published in Cancer Cell International, has provided new insights into the mechanisms of AID and its impact on immune
